Through electronic surveys, this study aims to prospectively understand the wide range of individual and systematic variables that impact a woman’s ability and interest in pursuing fertility preservation prior to cancer treatment. We will also monitor ovarian reserve through blood measurements and ultrasounds pre and post treatment to better understand the specific impact of the large number of cancer treatments patients undergo.
You may be eligible if you are: female (or assigned female at birth), aged 18-45, newly diagnosed with cancer
Mitchell Rosen, MD
Principal Investigator
